Abstract:Hydroxylated polychlorinated biphenyls (HO-PCBs), major metabolites of PCBs, have been reported to present agonist or antagonist interactions with estrogen receptor α (ERα) and induce ER-mediated responses. In this work, a multistep framework combining molecular docking, molecular dynamics (MD) simulations, and structure-based three-dimensional quantitative structure–activity relationship (3D-QSAR) studies were performed to explore the influence of structural features on the estrogenic activities of HO-PCBs, and to investigate the molecular mechanism of ERα–ligand interactions. The CoMSIA (comparative molecular similarity indices analysis) model was developed from the conformations obtained from molecular docking. The model exhibited statistically significant results as the cross-validated correlation coefficient q2 was 0.648, the non-cross-validated correlation coefficient r2 was 0.968, and the external predictive correlation coefficient rpred2 was 0.625. The key amino acid residues were identified by molecular docking, and the detailed binding modes of the compounds with different activities were determined by MD simulations. The binding free energies correlated well with the experimental activity. An energetic analysis, MM-GBSA energy decomposition, revealed that the van der Waals interaction was the major driving force for the binding of compounds to ERα. The hydrogen bond interactions between the ligands and residue His524 help to stabilize the conformation of ligands at the binding pocket. These results are expected to be beneficial to predict estrogenic activities of other HO-PCB congeners and helpful for understanding the binding mechanism of HO-PCBs and ERα.

Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor

Molecular Docking, Molecular Dynamics Simulation, and Structure-Based 3D-QSAR Studies on the Aryl Hydrocarbon Receptor Agonistic Activity of Hydroxylated Polychlorinated Biphenyls.

An Overview of Aryl Hydrocarbon Receptor Ligands in the Last Two Decades (2002–2022): A Medicinal Chemistry Perspective

Dietary phytochemicals as modulators of human pregnane X receptor

Aryl Hydrocarbon Receptor Pathway: Role, Regulation and Intervention in Atherosclerosis Therapy

Understanding ligands driven mechanism of wild and mutant aryl hydrocarbon receptor in presence of phytochemicals combating Parkinson’s disease: an in silico and in vivo study

The Aryl Hydrocarbon Receptor: A Key Bridging Molecule of External and Internal Chemical Signals.

The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications

Research progress on endogenous and exogenous ligands of aryl hydrocarbon receptor

The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis

Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization

An introduction to the molecular basics of aryl hydrocarbon receptor biology

Timing is everything: Consequences of transient and sustained AhR activity

Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: A strategy towards gut inflammation

AhR signaling pathways and regulatory functions

Dietary Natural Flavonoids Treating Cancer by Targeting Aryl Hydrocarbon Receptor

PXR- and CAR-mediated Herbal Effect on Human Diseases

An update on the dietary ligands of the AhR

Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor.

Chemical activation of estrogen and aryl hydrocarbon receptor signaling pathways and their interaction in toxicology and metabolism